SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000921895-23-001569
Filing Date
2023-06-23
Accepted
2023-06-23 16:07:41
Documents
1
Period of Report
2023-06-21

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT form413531001_06222023.html 4  
1 OWNERSHIP DOCUMENT form413531001_06222023.xml 4 7316
  Complete submission text file 0000921895-23-001569.txt   9296
Mailing Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080 6502444990
TITAN PHARMACEUTICALS INC (Issuer) CIK: 0000910267 (see all company filings)

IRS No.: 943171940 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR. NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR. NEW YORK NY 10036 646 768 8417
Activist Investing LLC (Reporting) CIK: 0001817604 (see all company filings)

State of Incorp.: NY | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-13341 | Film No.: 231037734

Mailing Address VILLA 1, 14-43RD STREET JUMEIRAH 2 DUBAI C0 00000
Business Address
Lazar David E. (Reporting) CIK: 0001932843 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-13341 | Film No.: 231037735